HFS
ANIP icon

Hantz Financial Services’s ANI Pharmaceuticals ANIP Stock Holding History

Hantz Financial Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52K Buy
624
+266
+74% +$21.3K ﹤0.01% 1640
2026
Q1 		$28K Sell
358
-245
-41% -$19.1K ﹤0.01% 1746
2025
Q4 		$48K Buy
603
+249
+70% +$21.6K ﹤0.01% 1449
2025
Q3 		$32K Buy
354
+237
+203% +$19.3K ﹤0.01% 1384
2025
Q2 		$8K Buy
+117
New +$7.62K ﹤0.01% 1569

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hantz Financial Services's ANIP Position: Q2 2026 in Review

Hantz Financial Services increased its ANI Pharmaceuticals (ANIP) stake by 74% in Q2 2026, buying an estimated $21.3K and bringing the position to 624 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Hantz Financial Services first reported a position in ANIP in Q2 2025 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Hantz Financial Services held 624 shares of ANI Pharmaceuticals worth $52K as of Q2 2026.
  • Hantz Financial Services bought 266 ANI Pharmaceuticals shares in Q2 2026, an estimated $21.3K.
  • ANI Pharmaceuticals made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1640 holding.
  • Hantz Financial Services first reported a position in ANI Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 283 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.